发明名称 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
摘要 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof, for the treatment of sub-type anxiety disorders chosen from the sub-types: panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication or generalized anxiety disorder, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, anorexia, and fibromyalgia. A preferred salt is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride.
申请公布号 US2005113386(A1) 申请公布日期 2005.05.26
申请号 US20040994226 申请日期 2004.11.23
申请人 发明人 BARTOSZYK GERD;SEYFRIED CHRISTOPH;VON AMSTERDAM CHRISTOPH;BOETTCHER HENNING;SEDMAN EWEN
分类号 C07D405/12;A61K31/00;A61K31/495;A61K31/496;A61P1/14;A61P3/04;A61P15/10;A61P21/00;A61P25/00;A61P25/22;A61P25/28;A61P29/00;(IPC1-7):A61K31/496 主分类号 C07D405/12
代理机构 代理人
主权项
地址